Clinical Trial: Maintaining Nonsmoking: Older Smokers


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Maintaining Nonsmoking: Older Smokers - 1

This study is currently recruiting patients.

Sponsored by:	National Institute on Drug Abuse (NIDA)
Information provided by:	National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to examine pharmacological and psychological interventions for smokers over 50.

Condition	Treatment or Intervention	Phase
Tobacco Use Disorder	Drug: Nicotine Polacrilex	Phase II

MedlinePlus related topics: Smoking

Study Type: Interventional
Study Design: Treatment, Uncontrolled, Efficacy Study

Official Title: Maintaining Nonsmoking: Older Smokers

Further Study Details:

Expected Total Enrollment: 448

Study start: September 2001

Eligibility

Ages Eligible for Study: 50 Years and above, Genders Eligible for Study: Both

Criteria

smokers of at least 10 cigarettes per day

Inclusion Criteria:

MULTIPLE

Exclusion Criteria:

MULTIIPLE

Location and Contact Information

Sharon M Hall, Ph.D. (415)476-7574 smh@itsa.ucsf.edu

California
San Francisco, San Francisco, California, 94143, United States; Recruiting

Sharon M Hall, Ph.D. 415-476-7574 smh@itsa.ucsf.edu

Study chairs or principal investigators

Sharon M Hall, Ph.D., Principal Investigator, University of California, San Francisco

More Information

Study ID Numbers: NIDA-02538-1; R01-02538-1
Record last reviewed: June 2004
Record first received: July 1, 2004
ClinicalTrials.gov Identifier: NCT00086385
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services